SAIC Schedules First Quarter Fiscal Year 2022 Earnings Press Release and Conference Call for June 3 at 5 p.m. EDT
Science Applications International Corp. (NYSE: SAIC) is scheduled to issue its first quarter fiscal year 2022 results and hold a conference call after close of market on Thursday, June 3, 2021. SAIC executive management will discuss operational and financial results in a conference call beginning at 5 p.m. Eastern Daylight Time following issuance of the Company's earnings press release.
The conference call will be webcast simultaneously to the public through a link on the Investor Relations section of the SAIC website (http://investors.saic.com). We will only be providing webcast access, and dial-in access will not be available. Additionally, a supplemental presentation will be available to the public through links to the Investor Relations section of the SAIC website.
After the call concludes, an on-demand audio replay of the webcast can be accessed on the SAIC Investor Relations website.
SAIC® is a premier Fortune 500® technology integrator driving our nation’s technology transformation. Our robust portfolio of offerings across the defense, space, civilian, and intelligence markets includes secure high-end solutions in engineering, digital, artificial intelligence, and mission solutions. Using our expertise and understanding of existing and emerging technologies, we integrate the best components from our own portfolio and our partner ecosystem to deliver innovative, effective, and efficient solutions that are critical to achieving our customers' missions.
We are more than 26,000 strong; driven by mission, united by purpose, and inspired by opportunities. Headquartered in Reston, Virginia, SAIC has annual revenues of approximately $7.1 billion. For more information, visit saic.com. For ongoing news, please visit our newsroom.
Certain statements in this release contain or are based on “forward-looking” information within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by words such as “expects,” “intends,” “plans,” “anticipates,” “believes,” “estimates,” “guidance,” and similar words or phrases. Forward-looking statements in this release may include, among others, estimates of future revenues, operating income, earnings, earnings per share, charges, total contract value, backlog, outstanding shares and cash flows, as well as statements about future dividends, share repurchases and other capital deployment plans. Such statements are not guarantees of future performance and involve risk, uncertainties and assumptions, and actual results may differ materially from the guidance and other forward-looking statements made in this release as a result of various factors. Risks, uncertainties and assumptions that could cause or contribute to these material differences include those discussed in the “Risk Factors,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and “Legal Proceedings” sections of our Annual Report on Form 10-K, as updated in any subsequent Quarterly Reports on Form 10-Q and other filings with the SEC, which may be viewed or obtained through the Investor Relations section of our website at saic.com or on the SEC’s website at sec.gov. Due to such risks, uncertainties and assumptions you are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date hereof. SAIC expressly disclaims any duty to update any forward-looking statement provided in this release to reflect subsequent events, actual results or changes in SAIC’s expectations. SAIC also disclaims any duty to comment upon or correct information that may be contained in reports published by investment analysts or others.
- InfuSystem Reports First Quarter 2021 Financial Results
- SEACOR Marine Announces First Quarter 2021 Results
- New CentoMD® 6.0 Update Brings Deeper Insights Into Rare Diseases
- PAE Reports First-Quarter 2021 Financial Results
- Wallbridge Continues to Produce Strong Drill Results from its Definition and Expansion Drill Program at Fenelon
- SpringWorks Therapeutics Reports First Quarter 2021 Financial Results and Recent Business Highlights